Efeito anti-osteoporótico do extrato de Ginkgo biloba em ratas Wistar com osteoporose induzida por glicocorticoides
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
Introduction: Among the major mechanisms that lead to osteoporosis is the use of
glucocorticoids. Glucocorticoids induce apoptosis in osteoblasts and reduce the total
bone volume. Several products are used in the treatment of osteoporosis and among
them, some natural products such as phytoestrogens. Studies with Ginkgo biloba
extract (EGb) showed promising effects in the treatment of osteoporosis. This study
aims to evaluate the effects of EGb on the apoptosis of osteoblasts, bone mineral
density and bone structure of Wistar rats with glucocorticoid-induced osteoporosis.
Methods: 60 rats were divided into 5 groups: control, osteoporosis, alendronate
(alendronate sodium - 0.2 mg/kg/day), EGb1 (EGb 28mg/kg/day) and EGb2 (EGb
56mg/kg/day). Osteoporosis was induced by injections of dexamethasone. The bone
alkaline phosphatase was measured in serum and immunohistochemical analysis of
the proteins Bcl-2 and Bax were evaluated in histological sections of the mandible
and femur. In the tibia were evaluated the bone mineral density (BMD), the
radiographic density, the cortical mineral density and the biomechanical parameters.
The control group was compared to the osteoporosis group ("t" test/ Mann Whitney).
The other groups, except the controls, were analyzed by ANOVA followed by Tukey
or Dunnett's T3 post hoc test (p <0.05). Results: In the osteoporosis group the levels
of bone alkaline phosphatase and the anti-apoptotic protein Bcl-2 expression were
significantly reduced. The BMD, cortical mineral density of the distal diaphysis,
stiffness, resilience and load of the tibia reduced (p<0.05). The radiographic density
of the distal tibial epiphysis and the expression of the pro-apoptic protein Bax
increased (p<0.05). Alendronate group decreased the expression of Bax (20 days),
and increased the expression of the Bcl-2 (30 days) and the BMD of the tibia (20 and
30 days) (p<0.05). EGb1 and EGb2 (30 days) increased the levels of bone alkaline
phosphatase (p<0.05). EGb2 increased BMD (20 and 30 days) (p<0.05). EGb1 and
EGb2 increased the expression of Bcl-2 (20 and 30 days) (p<0.05). EGb2 (20 days),
EGb1 and EGb2 (30 days) reduced the expression of Bax (p<0.05). EGb1 and EGb2
(20 and 30 days) reduced radiographic density (p<0.05). However treatment with
alendronate sodium and EGb did not increase significantly the biomechanical
parameters. Conclusion: EGb increased BMD, the expression of anti-apoptotic
proteins and bone alkaline phosphatase. The EGb reduced the radiographic density
and the expression of pro-apoptotic proteins. This study suggests that EGb reduces
apoptosis of osteoblastic cells and increases the formation of bone tissue. It suggests
that the EGb may be effective in the treatment of osteoporosis
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
